Adoptive T cell transfer, in which PD-1 was genetically disrupted, was performed in 12 patients suffering from metastatic non-small cell lung cancer (NSCLC) and 17 patients with advanced esophageal squamous cell carcinoma (ESCC). This evidence concerns the gene PDCD1 and esophageal squamous cell carcinoma.